Literature DB >> 23896355

Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.

Ruth Salo1, Catherine Fassbender, Ana-Maria Iosif, Stefan Ursu, Martin H Leamon, Cameron Carter.   

Abstract

The goal of this study was to extend our previous research that reported a significant association between Attention Deficit Hyperactivity Disorder (ADHD)-relevant childhood behaviors and the frequency of methamphetamine (MA)-induced psychotic symptoms in an expanded sample. 190 participants who met DSM-IV criteria for MA dependence were administered the Methamphetamine Experience Questionnaire that assessed MA-induced psychosis. Data related to MA exposure, comorbid drug use, education, familial psychiatric history and assessments of ADHD-relevant childhood behaviors as measured by the Wender Utah Rating Scale (WURS) were collected. Although WURS scores did not differ between 145 MAP+ and 45 MAP- subjects, MAP+ subjects with higher WURS scores were significantly more likely to report more frequent psychosis. Although mean daily MA dosage did not differ between the MAP+ and MAP- subjects, MAP+ subjects who consumed larger doses of MA were significantly more likely to experience frequent psychosis. These data suggest that ADHD-relevant childhood behaviors may interact with MA exposure to reflect a neurobiological vulnerability related to the emergence of frequent MA-induced psychotic symptoms. These results may elucidate factors that contribute to the psychiatric sequelae of MA abuse.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ADHD; Attention; Methamphetamine; Predictors; Prefrontal cortex; Psychosis; Substance abuse

Mesh:

Substances:

Year:  2013        PMID: 23896355      PMCID: PMC3818411          DOI: 10.1016/j.psychres.2013.06.030

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  73 in total

1.  Hospitalization of patients with cocaine and amphetamine use disorders from a psychiatric emergency service.

Authors:  Martin H Leamon; David R Gibson; Robert D Canning; Lloyd Benjamin
Journal:  Psychiatr Serv       Date:  2002-11       Impact factor: 3.084

2.  Methamphetamine use and schizophrenia: a population-based cohort study in California.

Authors:  Russell C Callaghan; James K Cunningham; Peter Allebeck; Tamara Arenovich; Gautam Sajeev; Gary Remington; Isabelle Boileau; Stephen J Kish
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 3.  Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.

Authors:  L S Seiden; K E Sabol
Journal:  NIDA Res Monogr       Date:  1996

4.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

Authors:  M F Ward; P H Wender; F W Reimherr
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

5.  Schizophrenia and substance abuse: the interface.

Authors:  A Berti
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1994-03       Impact factor: 5.067

6.  Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

Authors:  G A Ricaurte; L S Seiden; C R Schuster
Journal:  Brain Res       Date:  1984-06-15       Impact factor: 3.252

Review 7.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Authors:  G W Dalack; D J Healy; J H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

8.  Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.

Authors:  Rebecca McKetin; Dan I Lubman; Amanda L Baker; Sharon Dawe; Robert L Ali
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

Review 9.  Effects of cannabis use on outcomes of psychotic disorders: systematic review.

Authors:  Stanley Zammit; Theresa H M Moore; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Br J Psychiatry       Date:  2008-11       Impact factor: 9.319

10.  The epidemiology of schizophrenia: replacing dogma with knowledge.

Authors:  Simona A Stilo; Robin M Murray
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

View more
  7 in total

1.  Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data.

Authors:  Nathan C Nickel; Jennifer E Enns; Amy Freier; Scott C McCulloch; Mariette Chartier; Hera J M Casidsid; Oludolapo Deborah Balogun; Drew Mulhall; Roxana Dragan; Joykrishna Sarkar; James Bolton; Geoffrey Konrad; Wanda Phillips-Beck; Julianne Sanguins; Carolyn Shimmin; Neil McDonald; Javier Mignone; Aynslie Hinds
Journal:  BMJ Open       Date:  2022-10-19       Impact factor: 3.006

2.  Suicide behavior is associated with childhood emotion dysregulation but not trait impulsivity in first episode psychosis.

Authors:  Rebecca E Grattan; Valerie L Tryon; Cameron S Carter; Tara A Niendam
Journal:  Psychiatry Res       Date:  2020-10-22       Impact factor: 3.222

Review 3.  A Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms.

Authors:  Xiangwen Chang; Yan Sun; Yang Zhang; Jiana Muhai; Lin Lu; Jie Shi
Journal:  Front Psychiatry       Date:  2018-11-16       Impact factor: 4.157

4.  Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats.

Authors:  Effat Ramshini; Shahriar Dabiri; Shokouh Arjmand; Gholamreza Sepehri; Mohammad Khaksari; Meysam Ahmadi-Zeidabadi; Mohammad Shabani
Journal:  Addict Health       Date:  2017

Review 5.  Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.

Authors:  Cintya Nirvana Dutta; Leonardo Christov-Moore; Hernando Ombao; Pamela K Douglas
Journal:  Front Hum Neurosci       Date:  2022-09-26       Impact factor: 3.473

6.  A Study of the Prevalence of Psychiatric Disorders in Patients with Methamphetamine-Induced Psychosis.

Authors:  Mahin Eslami-Shahrbabaki; Alireza Fekrat; Shahrzad Mazhari
Journal:  Addict Health       Date:  2015 Winter-Spring

Review 7.  A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology.

Authors:  Travis A Wearne; Jennifer L Cornish
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.